One Health Group PLC Exercise of options and Total Voting Rights (2335U)

TIDMOHGR

RNS Number : 2335U

One Health Group PLC

27 March 2023

27 March 2023

One Health Group plc

("One Health" or the "Company")

Exercise of options and Total Voting Rights

One Health (AQSE: OHGR), a provider of NHS-funded medical procedures, announces that it has issued 476,760 new ordinary shares of 0.5 pence each in the Company (the "New Ordinary Shares") pursuant to the exercise of options under the One Health Group Share Option Plan.

An application has been made for the New Ordinary Shares to be admitted to trading on the Apex segment of the AQSE Growth Market ("Admission"). It is expected that Admission will become effective at 8.00 a.m. on or around 30(th) March 2023.

Following Admission, the total number of ordinary shares and voting rights in the Company will be 10,510,093. The Company does not hold any shares in treasury.

The above figure of 10,510,093 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The directors of One Health accept responsibility for this announcement.

Ends

Enquiries:

 
 One Health Group plc              Via Square1 Consulting 
 Oberon Capital (AQSE Corporate 
  Adviser and Broker) 
  Nick Lovering, Mike Seabrook              020 3179 5300 
 Square 1 Consulting 
  David Bick                                020 7929 5599 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXSEUESMEDSEID

(END) Dow Jones Newswires

March 27, 2023 02:00 ET (06:00 GMT)